Angiotensin II-induced MMP-2 release from endothelial cells is mediated by TNF-alpha (Q44673765)

5 December 2017

Angiotensin II-induced MMP-2 release from endothelial cells is mediated by TNF-alpha (English)

1 reference

5 December 2017

0 references

0 references

Ivan A Arenas

1

1 reference

5 December 2017

Yi Xu

series ordinal

2

1 reference

5 December 2017

Patricio Lopez-Jaramillo

series ordinal

3

1 reference

5 December 2017

Sandra T Davidge

series ordinal

4

1 reference

5 December 2017

26 November 2003

1 reference

American Journal of Physiology - Cell Physiology

5 December 2017

1 reference

5 December 2017

286

1 reference

5 December 2017

4

1 reference

5 December 2017

C779-84

1 reference

Tissue renin-angiotensin systems: new insights from experimental animal models in hypertension research

5 December 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00398.2003

A specific and reliable bioassay for the detection of femtomolar levels of human and murine tumor necrosis factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00398.2003

Experimental and clinical evidence that angiotensin II is an independent risk factor for cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00398.2003

Endothelial activation by angiotensin II through NFkappaB and p38 pathways: Involvement of NFkappaB-inducible kinase (NIK), free oxygen radicals, and selective inhibition by aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00398.2003

The role of TNF in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00398.2003

Tumor necrosis factor antagonism with etanercept improves systemic endothelial vasoreactivity in patients with advanced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00398.2003

Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00398.2003

Synthesis of Antihemophilic Factor Antigen by Cultured Human Endothelial Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00398.2003

Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00398.2003

Angiotensin II induces tumor necrosis factor biosynthesis in the adult mammalian heart through a protein kinase C-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00398.2003

TNF signaling in vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00398.2003

Losartan inhibits the angiotensin II-induced modifications on fibrinolysis and matrix deposition by primary human vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00398.2003

Angiotensin II stimulates intercellular adhesion molecule-1 (ICAM-1) expression by human vascular endothelial cells and increases soluble ICAM-1 release in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00398.2003

Tumor necrosis factor-alpha-induced AT1 receptor upregulation enhances angiotensin II-mediated cardiac fibroblast responses that favor fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00398.2003

Role of the renin-angiotensin system in vascular diseases: expanding the field.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00398.2003

How matrix metalloproteinases regulate cell behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00398.2003

10.1152/AJPCELL.00398.2003

21 January 2018

Identifiers

DOI

1 reference

5 December 2017

1 reference